Cancer news

Latest news, press releases and blog posts from Cancer Research UK.


Mesothelioma Awareness Day: How research is tackling the deadly legacy of asbestos

A greater understanding of the biology of mesothelioma has led to new clinical trials testing immunotherapies and targeted drugs against the disease.

Cancer Research UK and Biotecnol to trial new immuno-oncology treatment for advanced tumours

Cancer Research UK and Biotecnol Limited will trial an experimental immuno-oncology treatment for some patients with advanced tumours.

The trans-Atlantic quest to find a winning combination of cancer drugs

An exciting new partnership will see a combination of drugs tested in mesothelioma, lung and pancreatic cancers for the first time.

Study sheds new light on asbestos-related cancer

US scientists analysing tumour samples from patients with mesothelioma have mapped out the gene faults associated with the disease in unprecedented detail.

Dampening the immune system improves response to mesothelioma treatment

Suppressing the body's natural defences could improve how well mesothelioma patients respond to certain treatments, a US study suggests.

Asbestos linked to cancer of the ovaries and larynx

Exposure to asbestos, which is known to cause a form of cancer called mesothelioma, has also been shown to cause some cancers of the ovary and larynx (voice box) as well,...

Survey finds widespread ignorance of asbestos, cancer link

A new survey has revealed widespread ignorance of the health risks posed by asbestos, with under a third of tradespeople recognising that it can cause cancer.

NICE to reconsider Alimta ruling

The National Institute of Health and Clinical Excellence (NICE) has said it is to reconsider its decision that a drug for asbestos-related lung cancer should not be...

Cancer Research UK calls for reconsideration of Alimta decision

Cancer Research UK has contacted the health secretary to ask that Nice, the UK drugs regulator, reconsider its decision not to make the lung cancer drug Alimta available...

Experimental vaccine shows early promise against mesothelioma

A vaccine against mesothelioma, a cancer associated with exposure to asbestos, has shown early promise in its first clinical trial.